Carolyn J. Henry
Associate Professor, Oncology
Office Address: 373A Clydesdale Hall
Mailing Address:

379 E. Campus Drive , Department of Veterinary Medicine & Surgery, College of Veterinary Medicine , UMC, Columbia , MO 65211

Phone: (573)-882-7821
Fax: (573)-884-5444
Email: HenryC@missouri.edu
URL:

http://www.vmth.missouri.edu/


Education:

1994

DACVIM Medical Oncology, American College of Veterinary Internal Medicine, Lakewood, CO
1993 MS Small Animal Surgery/Medicine, Auburn University, Auburn, AL
1990 DVM Veterinary Medicine, Auburn University, Auburn, AL
1987 BS Animal Science/Biology Eastern Kentucky University, Richmond, KY
Professional Experience:

2003-Present

Associate Professor of Oncology
2002-present Director, Tom and Betty Scott Endowed Program in Veterinary Oncology, University of Missouri-Columbia
2001-present Assistant Professor, Oncology, Internal Medicine, Hematology/Oncology, School of Medicine (dual appt), University of Missouri-Columbia
1997-present Assistant Professor, Oncology, Veterinary Medicine and Surgery, University of Missouri-Columbia
1993-1997 Assistant Professor, tenure track, Veterinary Clinical Sciences, Washington State University, Pullman, WA
1992-1993 Emergency Care Veterinarian, part-time, Columbus Animal Emergency Center, Columbus, GA.
1991-1993 Oncology Resident/MS Candidate, Small Animal Surgery and Medicine, Veterinary Medicine, Auburn University.
1990-1991 Associate Veterinarian, Animal Care Center, Prattville, AL.
1991-1993 Emergency Care Veterinarian, part-time, Montgomery AL. Animal Emergency Clinic
Recent Publications:
  1. Henry CJ, McCaw DL, Turnquist SE, Tyler JW, Bravo L, Sheafor S, Straw RC, Dernell WS, Madewell BR, Jorgensen L, Scott MA, Higginbotham ML, Chun R. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clinical Cancer Research 2003;9:906-911.
  2. Higginbotham ML, Henry CJ, Katti KV, Casteel SW, Dowling PM, Pillarsetty N. Preclinical tolerance and pharmacokinetic assessment of MU-Gold, a novel chemotherapeutic agent, in laboratory dogs. Vet Therapeutics 2003;4:76-82.
  3. Henry CJ. Management of transitional cell carcinoma. Vet Clinics of North America Small Anim Prac 2003;33:597-613.
  4. Henry CJ, Tyler JW, McEntee MC, Stokol T, Rogers KS, Chun R, Garrett LD, McCaw DL, Higginbotham ML, Flessland KA, Stokes PK. Evaluation of a bladder tumor antigen test as a screening test for transitional cell carcinoma of the lower urinary tract in dogs. Am J Vet Research 2003;64(8):1017-1020.
  5. Moore AS , Nelson RW, Henry CJ, et al. A diuresis protocol for administration of streptozotocin to dogs with pancreatic islet cell tumors. J Am Vet Med Assoc 2002;221(6):811-818.
  6. Fox DB, Cook JL, Kreeger JM, Beissenherz M, Henry CJ. Canine synovial sarcoma: a retrospective assessment of described prognostic criteria in 16 cases. J Am Anim Hosp Assoc 2002;38:347-355.
  7. Clifford CA, Hughes D, Beal MW, Henry CJ, et al. Vascular endothelial growth factor concentrations in body cavity effusions in dogs. J Vet Int Med 2002;164-168.